Myocardial Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
1800
|
680
|
0.450 |
None |
0.857 |
7 |
2
|
2009 |
2015 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.310 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Coronary heart disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1576
|
1178
|
0.120 |
None |
1.000 |
4 |
2
|
2009 |
2013 |
Alcoholic Intoxication, Chronic
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
577
|
441
|
0.120 |
None |
1.000 |
4 |
2
|
2009 |
2019 |
Drinking behavior processes
|
disease |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
7
|
31
|
0.100 |
None |
1.000 |
2 |
1
|
2011 |
2013 |
Hepatitis B
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
1449
|
519
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Serum Alanine Aminotransferase Measurement
|
phenotype |
|
Laboratory Procedure
|
41
|
77
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Corpuscular Hemoglobin Concentration Mean
|
phenotype |
|
Laboratory or Test Result
|
401
|
4389
|
0.100 |
None |
1.000 |
1 |
5
|
2012 |
2012 |
Platelet Count measurement
|
phenotype |
|
Laboratory Procedure
|
265
|
457
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Alcohol consumption
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
210
|
535
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Malignant neoplasm of esophagus
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1286
|
214
|
0.100 |
None |
1.000 |
1 |
2
|
2011 |
2011 |
Folic acid measurement
|
phenotype |
|
Laboratory Procedure
|
3
|
8
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
C-reactive protein measurement
|
phenotype |
|
Laboratory Procedure
|
135
|
624
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Alanine aminotransferase measurement
|
phenotype |
|
Laboratory Procedure
|
41
|
77
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Uric acid measurement (procedure)
|
phenotype |
|
Laboratory Procedure
|
264
|
1463
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Alcohol-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
54
|
180
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Alcohol-Induced Disorders
|
group |
Chemically-Induced Disorders
|
Disease or Syndrome
|
50
|
180
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.060 |
None |
1.000 |
6 |
|
2001 |
2020 |
Coronary Artery Disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1708
|
1577
|
0.040 |
None |
1.000 |
4 |
1
|
2009 |
2013 |
Coronary Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1282
|
440
|
0.040 |
None |
0.750 |
4 |
1
|
2009 |
2013 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2020 |
Lewy Body Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
255
|
41
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2019 |
Metabolic Syndrome X
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1125
|
591
|
0.030 |
None |
1.000 |
3 |
2
|
2011 |
2016 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
3097
|
353
|
0.030 |
None |
1.000 |
3 |
|
2010 |
2020 |